ASCVD Risk estimator - Evidencio
ASCVD Risk estimator

The current tool is used to estimate the 10-year Atherosclerotic Cardiovascular Disease (ASCVD) risk.  The ASCVD Risk Estimator is intended for patients without a prior atherosclerotic cardiovascular event or disease, between 40 and 79 years of age.

Contra-indications:

The ASCVD Risk Estimator is not intended for patients who have already had an atherosclerotic cardiovascular event or disease.    

Forskende forfattere: David C. Goff Jr., Donald M. Lloyd-Jones, Glen Bennett, Sean Coady, Ralph B. D'Agostino, Raymond Gibbons, Philip Greenland, Daniel T. Lackland, Daniel Levy, Christopher J. O'Donnell, Jennifer G. Robinson, J. Sanford Schwartz, Susan T. Shero, Sidney C. Smith Jr., Paul Sorlie, Neil J. Stone, Peter W.F. Wilson
Versjon: 1.23
  • Offentlig
  • Kardiologi
  • {{ modelType }}
V-1.23-2903.25.05.22
(01)08719327522783(8012)v1.23(4326)250522(240)2903
Last ned Brukerhåndbok og konsultere Tiltenkt bruk.
  • Algorithm
  • Detaljer
  • Tiltenkt bruk
  • Elektronisk etikett
  • Utgivelsesmerknader
  • Brukerhåndbok
  • Språk
    English German French Italian Dutch Spanish

  • {{ toolbarErrorMessage }}

Enheter

{{ section.title }}

{{ section.description }}

Beregne resultatet

Angi flere parametere for å utføre beregningen

10-year ASCVD Risk is: %

{{ resultSubheader }}
{{ $t('download_result_availability') }}
{{ chart.title }}
Resultatintervall {{ additionalResult.min }} til {{ additionalResult.max }}

Betinget informasjon

Tekstinnlegget/innleggene dine er endret. Oppdater resultatet ditt. Oppdatering

The result of the ASCVD Risk Estimator can be used to inform a dialogue between a physician and their patient about their risk of cardiovascular disease, and guide discussions surrounding risk-reducing interventions, such as life-style intervention or preventative medication.

The ASCVD Risk Estimator was originally derived in a US cohort of patients, and may overestimate or underestimate risks in other populations. However, its discriminative ability remains good (AUROC: 0.75 (95% CI: 0.74, 0.77))

When deciding upon the use of preventative medications such as statins, it is recommended to use not just the 10-year ASCVD Risk, but also look at the individual risk factors for a patient. Precise risk categories depend and vary based upon the target population and the local guidance organisation, but risks above 10% are generally considered high, and risks above 20% very high.

{{ file.classification }}
PRO
Merknad
Notater er bare synlige i resultatnedlastingen og lagres ikke av Evidencio.

Beregninger alene bør aldri diktere pasientbehandlingen, og kan ikke erstatte faglig skjønn. Se hele vår disclaimer.

Underliggende algoritmer En del av
logo

Logg inn for å aktivere Evidencios utskriftsfunksjoner.

For å kunne bruke Evidencios utskriftsfunksjoner må du være logget inn.
Hvis du ikke har en Evidencio Community-konto, kan du opprette en gratis personlig konto på:

https://www.evidencio.com/registration

Trykte resultater - Eksempler {{ new Date().toLocaleString() }}

Fordeler med Evidencio Community Account

With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.

Ansvarsfraskrivelse: Beregninger alene bør aldri være styrende for pasientbehandlingen, og kan ikke erstatte faglig skjønn.
Terms & Conditions Privacy Policy Disclaimer Contact Refuse cookies
Evidencio v3.40 © 2015 - 2026 Evidencio. All Rights Reserved